Rheumnow Podcast

By Dr. CushMedicine Health & Fitness

Favorites
58
Followers
Typical duration
28 min
per episode

Based on Podcast App listening data

Rheumnow Podcast episodes

June 19, 2025 EULAR 2025 – SpA Panel Discussion
Leading rheumatology experts discuss the latest research, treatment advances, and clinical insights in axial spondyloarthritis. Hear what’s new from EULAR 2025 and what it means for improving patient outcomes.
37 min
June 19, 2025 EULAR 2025 - Day 7 podcast
Digital Behavioural Therapy for Persistent Pain in Axial Spondyloarthritis
There's an App for That (and it works): the AXIA RCT
15 min
June 18, 2025 EULAR 2025 - Day 6 podcast
Eular 2025 PsA Topic Panel
Assessment of Peripheral Arthritis in Spondyloarthritis
IL-17 inhibitors - Novel Drugs
IL17 inhibitors - Long-term Extensions and Uveitis
IL17 inhibitors - STAMP T2T and Combinations
Using AI for Reading PET/CT in Rheumatoid Arthritis
1 hr 7 min
June 17, 2025 Eular 2025 PsA Topic Panel
41 min
June 17, 2025 EULAR 2025 – RA Panel Discussion
Leading experts in rheumatology dive into the latest advances, treatment strategies, and emerging research in rheumatoid arthritis. Don’t miss this in-depth panel as they unpack key findings from EULAR 2025 and discuss what’s next for RA care.
51 min
June 16, 2025 EULAR2025 Topic Podcast IL-17
Efficacy and Safety of Xeligekimab in AS
Sonelokimab in PsA
Seronegative Arthritis Breakthroughs
Novel Therapies in Axial Spondyloarthritis
14 min
June 16, 2025 EULAR2025 Topic Podcast RA2
JAK Inhibitors: The Latest from the JAK-pot Study
Does Abatacept Buy You Time Off RA?
How to Properly Use Steroids in Early RA: Oral vs Parenteral
All Rheumatoid Arthritis is Not the Same
Jekyll and Hyde: which RA-ILD is it?
RA treatment: A Constant State of Evolution
30 min
June 16, 2025 EULAR2025 Topic Podcast RA1
Who/When to Treat Clinically Suspect Arthralgia
Thoughtful, Effective RA Care Should be Guided by Need —Not Age
The Impact of Biologics on Methotrexate Adherence
Jokes Aside: The Impact of Laughter in RA
JAK Safety Update
Why is RA Difficult to Treat?
DMARD Combinations in RA Treatment
Increased Risk of VTE in RA: Lessons Learned from 40 Years of Data
ALTO: Long-term Outcomes of APIPPRA
54 min
June 16, 2025 EULAR2025 Topic Podcast SpA
Efficacy and Safety of Xeligekimab in AS
Lessons on Uveitis and AxSpA
Difficult to Treat Axial Spondyloarthritis
MRI Lesions in Early axSpA vs Non-axSpA
Emerging Therapies in Axial Spondyloarthritis
Chronic Pain in AxSpA Beyond Fibromyalgia
Novel Therapies in Axial Spondyloarthritis
GLP 1 Receptor Agonists in axSpA Patients
32 min
June 16, 2025 EULAR2025 Topic Podcast PsA 2
Difficult to Treat Psoriatic Arthritis
Less or more frequent dosing in PsA?
Complex-to-Manage PsA: The GRAPPA Framework and Definition
Biologic Switching in PsA
Decoding Difficult to Treat PsA
Deucravacitinib in Psoriatic Arthritis: A New Oral Option with Dual Impact
27 min